Table 2.

Efficacy and Toxicity in Each Group

Response	Integrated, % (n)	Chemotherapy, % (n)	P Value
Response rate	9.10% (3/33)	6.45% (2/33)	.70
Disease control rate	39.39% (13/33)	30.30% (10/33)	.60
No progression rate at 6 months	21.2% (7/33)	12.1% (4/33)	.04
Toxicity
Grade 3 myelosuppression	12.1% (4/33)	12.1% (4/33)	1.00
Grade 2 skin rash	9% (3/33)	0	.238
Diarrhea ≤ 2	36.4% (10/33)	6.0% (2/33)	.02